Literature DB >> 24711470

Multiple ring-enhancing lesions: diagnostic dilemma between neurocysticercosis and tuberculoma.

Rajesh Verma1, Rahul Gupta.   

Abstract

Multiple ring-enhancing lesions in the brain often raise many questions about the true diagnosis. The aetiologies are many neoplastic, infectious, vascular, inflammatory and demyelinating conditions and also depend on the geographical location of the patient. The two important causes of multiple ring-enhancing lesions in the cranium are multiple neurocysticercosis and multiple tuberculomas in developing countries like India. This case report illustrates how multiple ring-enhancing lesions cause a diagnostic dilemma between neurocysticercosis and tuberculoma. A young girl with a typical presentation of neurocysticercosis finally turned out to be a case of tuberculoma. A high index of suspicion is required in appropriate clinical settings to have best clinical outcome.

Entities:  

Mesh:

Year:  2014        PMID: 24711470      PMCID: PMC3987544          DOI: 10.1136/bcr-2013-202528

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

1.  Discrimination of brain abscess from necrotic or cystic tumors by diffusion-weighted echo planar imaging.

Authors:  T Ebisu; C Tanaka; M Umeda; M Kitamura; S Naruse; T Higuchi; S Ueda; H Sato
Journal:  Magn Reson Imaging       Date:  1996       Impact factor: 2.546

2.  Clinical spectrum of 500 children with neurocysticercosis and response to albendazole therapy.

Authors:  P Singhi; M Ray; S Singhi; N Khandelwal
Journal:  J Child Neurol       Date:  2000-04       Impact factor: 1.987

Review 3.  Proposed diagnostic criteria for neurocysticercosis.

Authors:  O H Del Brutto; V Rajshekhar; A C White; V C Tsang; T E Nash; O M Takayanagui; P M Schantz; C A Evans; A Flisser; D Correa; D Botero; J C Allan; E Sarti; A E Gonzalez; R H Gilman; H H García
Journal:  Neurology       Date:  2001-07-24       Impact factor: 9.910

4.  Pattern of T2 hypointensity associated with ring-enhancing brain lesions can help to differentiate pathology.

Authors:  K M Schwartz; B J Erickson; C Lucchinetti
Journal:  Neuroradiology       Date:  2006-01-31       Impact factor: 2.804

5.  Neurocysticercosis in children: clinical characteristics and outcome.

Authors:  Bibek Talukdar; Anurag Saxena; Vineet Kumar Popli; Veena Choudhury
Journal:  Ann Trop Paediatr       Date:  2002-12

6.  Neurocysticercosis: a new classification based on active and inactive forms. A study of 753 cases.

Authors:  J Sotelo; V Guerrero; F Rubio
Journal:  Arch Intern Med       Date:  1985-03

Review 7.  Toxoplasmosis.

Authors:  J G Montoya; O Liesenfeld
Journal:  Lancet       Date:  2004-06-12       Impact factor: 79.321

8.  Multiple ring enhancing brain lesions on computed tomography: an Indian perspective.

Authors:  Ravindra Kumar Garg; Parthiv Desai; Minakshi Kar; Alok Mohan Kar
Journal:  J Neurol Sci       Date:  2007-10-22       Impact factor: 3.181

  8 in total
  4 in total

1.  Giant Tuberculomas of Brain: Rare Neoplastic Mimic.

Authors:  Chandradev Sahu; Nishant Bhargava; Vivek Singh; Pranav Dwivedi
Journal:  J Pediatr Neurosci       Date:  2020-11-06

2.  Monocyte Gene Expression Distinguishes Enhancing Brain Parenchymal Cysticercal Granulomas From Tuberculomas.

Authors:  Betcy Evangeline Pamela; Prabhakaran Vasudevan; Subashini Thamizhmaran; Ranjith K Moorthy; Anna Oommen; Josephin Manoj; Anupriya Thanigachalam; Miao Zhang; Douglas A Drevets; Hélène Carabin; Vedantam Rajshekhar
Journal:  Open Forum Infect Dis       Date:  2021-08-12       Impact factor: 3.835

3.  Intracranial tuberculomas or neurocysticercosis: differentiated by cervical lymph node pathology.

Authors:  Sevda Diker; Derlen Özgeç Ruso; Nesil Bayraktar; Uğurcan Balyemez
Journal:  Egypt J Neurol Psychiatr Neurosurg       Date:  2022-10-10

4.  The value of whole lesion ADC histogram profiling to differentiate between morphologically indistinguishable ring enhancing lesions-comparison of glioblastomas and brain abscesses.

Authors:  Diana Horvath-Rizea; Alexey Surov; Karl-Titus Hoffmann; Nikita Garnov; Cathrin Vörkel; Patricia Kohlhof-Meinecke; Oliver Ganslandt; Hansjörg Bäzner; Georg Alexander Gihr; Marcell Kalman; Elina Henkes; Hans Henkes; Stefan Schob
Journal:  Oncotarget       Date:  2018-04-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.